If you’re going to invest in the baby boomer demographic, the strategy isn’t to invest in stocks like Harley Davidson (HOG:NYSE) and bank on what they’re going to buy with their increasing purchase power, but to invest in the healthcare innovations that will extend their life expectancy and cure ailments.

There’s no discounting the strength of the baby boomer demographic. They’re 76 million strong. But as they continue to age, health ailments will plague them in greater numbers, and the medical technology companies that will aid in better disease-fighting techniques and faster recovery are about to go gangbusters.

A prime example, and an obvious one, is the joint replacement industry. From now until the year 2030, hip replacement surgeries will increase 174% and knee replacement surgeries will increase a drastic 673%. This is mainly due to the insistence by baby boomers themselves to stay active for as long as possible.

According to Science Daily, approximately 300,000 hip replacements are now performed annually, with projections for as many as 600,000 a year by 2015. And the American Academy of Orthopedic Surgeons says that in just seven years, the number of knee replacement surgeries has almost doubled, from 266,000 in 1998 to 455,000 in 2004.

What you may not know is that there’s a problem plaguing the joint replacement industry that could put some artificial joint companies out of business. Artificial joint replacements only last for roughly 10 years, and then patients need to undergo revision surgeries to correct and prolong the use of their joints. Also, titanium costs are rising, forcing joint replacement companies to find cost-effective alternative materials in these surgeries.

One specific medical technology company is set to profit from increases in joint replacement surgeries. Taking advantage of an exclusive deal with a remote cattle ranch near Mt. Shasta in Northern California and using its proprietary cleansing technology to eliminate any causes of infection, this small joint replacement company has the ability to take advantage of the growing market of joint replacement surgeries. And it can make 1,000% more bone grafts from one of its “secret material” bones than from comparable human bone donations.

If you find out about it today, you could make up to 355% on this one medical technology stock.

You have the exclusive opportunity at American Capitalist to learn more about this baby boomer medical technology stock today. Once you learn about this stock, the door will be open to you to learn more about the other baby boomer medical technology stocks I’m following in Diligent Investor.

I’ve been following this trend for some time now, starting with my Almost Family Inc. (AFAM:NASDAQ) pick and I have found some specific opportunities that will offer you gains that you simply can’t live without.

See, another condition that will plague baby boomers over the long haul is cardiovascular disease. There’s one company out there that has the FDA approval to use excimer, or cold laser, technology, which was fully developed during the Cold War to treat arterial blockages. This is similar to technology currently used for Lasik eye surgery.

Most recently, this company’s newest product was FDA approved for treating blocked arteries in patients’ legs, where many clots occur. This medical technology company’s cold laser will be used to treat the one in three Americans that suffer from cardiovascular disease.

And its proprietary technology, being used in growing numbers day by day, can replace current bypass surgeries that take longer to undergo and result in longer healing times. Best of all, the technology this company offers is reimbursable through healthcare insurance and Medicare. That’s music to baby boomers’ ears!

This company could make you an additional gain of 133% in the next 12 months.

And it’s still available at current prices for Diligent Investor subscribers.

And what about hearing loss, another affliction that comes with age? A third of Americans currently older than 60 have a hearing impairment… and that rises by 50% once people reach the age of 75.

There’s only one pure play in the United States that aids boomers with hearing loss. You could say it has a monopoly on the hearing aid industry. Its digital hearing aids are designed, developed and marketed with patented technology that consists of the smallest chip ever to be embedded in a hearing aid.

Since it’s the only pure play in America, it’s a surefire win for investors interested in trend investing within the boomer demographic. You could very easily double your money in the next 12 months.

In fact, this recommendation will be available to current Diligent Investor subscribers next week, so you still have time to become a member, and get in at the lowest price possible!

Investing in these medical technology companies that are allowing older Americans to enjoy life to the fullest and stay active for as long as possible is the smart way to long-term gains.

I hope you’ll take advantage of this opportunity by learning today about the joint replacement medical technology company that’s poised to be the next winner in the industry.

Ann

 

Related Stories

Tech Investing: Patching Together the Wireless Quilt of America

8/31/2007

Investing in Technology: New iPod Brings Fresh Buying Opportunity on Apple

8/30/2007

Chinese Stocks: Hard Commodity Outlooks and Hong Kong Trading Boosts Chalco

8/28/2007